Banner
  • Utilizing Medical Malpractice Data to Mitigate Risks and Reduce Claims
  • Industry News
  • Access and Reimbursement
  • Law & Malpractice
  • Coding & Documentation
  • Practice Management
  • Finance
  • Technology
  • Patient Engagement & Communications
  • Billing & Collections
  • Staffing & Salary

Poll: Have You Started Preparing for Stage 2 Rules of Meaningful Use?

Poll

Physicians face major challenges meeting the requirements for Stage 2 of the EHR incentive program. Let us know if your practice has started preparing.

Providers who successfully attested to Stage 1 of the government's EHR incentive program in 2011 can now participate in Stage 2.

But anecdotal evidence suggests that Stage 2 is off to a slow start, according to a recent article appearing in Healthcare IT News. According to the article, providers face big challenges in meeting the Stage 2 requirements, including difficulty balancing the incentive program with other health reform initiatives, and difficulty meeting the patient engagement requirements.

Furthermore, if you are behind your peers in attesting for Stage 1, it's not as easy to catch up.

While these challenges should come as no surprise to physicians, they serve as a reminder that physicians should heavily prepare if they hope to satisfy the Stage 2 requirements.
 

Have you started preparing for the Stage 2 rules to meet meaningful use?

Yes. We are preparing to attest.
No. We don't plan on attesting.
A bit. We have begun familiarizing ourselves with the requirements, but have not done much beyond that.
Not yet. We are still focused on Stage 1.
Recent Videos
Jennifer Wiggins
Jennifer Wiggins
MGMA comments on automation of prior authorizations
Ike Devji, JD and Anthony Williams discuss wealth management issues
Erin Jospe, MD gives expert advice
A group of experts discuss eLearning
Three experts discuss eating disorders
Ike Devji, JD and Anthony Williams discuss wealth management issues
Navaneeth Nair gives expert advice
Navaneeth Nair gives expert advice
Related Content
© 2024 MJH Life Sciences

All rights reserved.